首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

市場調查報告書

商品編碼

1477294

注射器市場，依用途、依應用、依最終用戶、依地理位置

Syringe Market, By Usage, By Application, By End User, By Geography

出版日期: 2024年04月12日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2024年注射器市值為219.8億美元，預計到2031年將達到410.6億美元，2024年至2031年的年複合成長率(CAGR)為9.3%。

報告範圍		報告詳情
基準年：	2023年	2024 年市場規模：	219.8 億美元
歷史數據：	2019年至2023年	預測期：	2024年至2031年
預測 2024 年至 2031 年複合年成長率：	9.30%	2031 年價值預測：	410.6 億美元

圖 1. 注射器市場佔有率 (%)（依地區），2024 年

過去幾十年來，全球注射器市場一直穩定成長。注射器是用於向人體注射或抽取液體的重要配件。它由連接到圓柱形管的空心針和桶內的柱塞組成。注射器廣泛應用於醫療過程中輸送疫苗、胰島素等藥物。人口結構的變化以及易患糖尿病等慢性疾病的老齡化人口的增加，大大增加了對注射器的需求。此外，傳染病的日益普及以及全球範圍內免疫計劃的增加是市場成長的關鍵驅動力。然而，有關注射器重複使用和處置的嚴格規定給市場參與者帶來了課題。旨在開發更方便用戶使用且更具成本效益的注射器的持續技術創新預計將為未來幾年的市場擴張提供新的機會。

市場動態：

全球注射器市場主要是由全球慢性和傳染病發病率上升所推動的，這增加了醫療保健產業對注射器的需求。據估計，慢性病每年影響超過1.43億美國人，佔全國醫療保健總支出的50%以上。尤其是糖尿病，已成為一個主要的公共衛生問題，光在美國就影響了超過 3000 萬人。預計這將顯著增加對胰島素注射器的需求。此外，已開發國家和發展中國家的政府和醫療機構越來越重視免疫和疫苗接種計劃，這有利於市場成長。然而，嚴格的注射器處置和再利用法規是市場參與者的主要限制因素。另一方面，持續研發以開發更方便用戶且價格實惠的注射器，為市場擴張提供了新的機會。注射器製造商正在設計具有改進的人體工學、安全功能的產品，並提供預先安裝藥物的產品，以提高注射器的採用率。

研究的主要特點：

該報告對全球注射器市場進行了深入分析，並提供了以 2023 年為基準年的預測期（2024-2031 年）的市場規模（十億美元）和年複合成長率（CAGR%）。
它闡明了不同區隔市場的潛在收入成長機會，並解釋了該市場有吸引力的投資主張矩陣。
這項研究還提供了有關市場促進因素、限制因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採取的競爭策略的重要見解。
它根據以下參數對全球注射器市場的主要參與者進行了介紹——公司亮點、產品組合、主要亮點、財務表現和策略。
該報告的見解將使行銷人員和公司管理當局能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球注射器市場迎合了該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進業者和財務分析師。
利害關係人可以透過用於分析全球注射器市場的各種策略矩陣輕鬆做出決策。

介紹
北美洲
美國
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
拉丁美洲其他地區
歐洲
英國
德國
義大利
法國
西班牙
俄羅斯
歐洲其他地區
亞太地區
中國
印度
日本
東協
澳洲
韓國
亞太地區其他地區
中東
海灣合作理事會
以色列
中東其他地區
非洲
北非
中非
南非

第 9 章：競爭格局

公司簡介
- ICU Medical, Inc.
- CODAN Companies
- Catalent, Inc.
- BD
- Hindustan Syringes & Medical Devices Ltd
- Terumo Corporation
- Schott AG
- Cardinal Health
- B. Braun SE
- Gerresheimer AG
- NIPRO
- Gerresheimer AG
- Dali Medical Devices
- Zephyrus Innovations (Zephyrus)
- Stevanato Group
- Xellia Pharmaceuticals
- Delta Med Group

第 10 章：分析師觀點

命運之輪
分析師觀點
連貫的機會圖

第 11 章：參考文獻與研究方法

參考
研究方法論

簡介目錄

Product Code: CMI917

The syringe market is estimated to be valued at USD 21.98 Bn in 2024 and is expected to reach USD 41.06 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 9.3% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 21.98 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	9.30%	2031 Value Projection:	US$ 41.06 Bn

Figure 1.Syringe Market Share (%), By Region, 2024

The global syringe market has been witnessing steady growth over the past few decades. A syringe is an essential accessory used for injecting or extracting fluids from the human body. It consists of a hollow needle attached to a cylindrical tube and plunger within a barrel. Syringes find widespread application for delivering medications such as vaccines, insulin, and others during medical procedures. Changing demographics with rising aging population susceptible to chronic diseases like diabetes have significantly boosted the demand for syringes. Moreover, the growing prevalence of infectious diseases coupled with increasing immunization programs across the globe acts as a key growth driver for the market. However, stringent regulations concerning the reuse and disposal of syringes pose a challenge to market players. Ongoing technological innovations aimed at developing more user-friendly and cost-effective syringes are expected to provide new opportunities for market expansion in the coming years.

Market Dynamics:

The global syringe market is primarily driven by rising incidence of chronic and infectious diseases worldwide which has increased the demand for syringes from the healthcare industry. According to estimates, chronic diseases affect over 143 million Americans annually, accounting for more than 50% of the total healthcare spending in the country. Diabetes, in particular, has emerged as a major public health concern affecting over 30 million people in the U.S. alone. This is expected to significantly boost the demand for insulin syringes. Furthermore, growing emphasis on immunization and vaccination programs by governments and healthcare agencies across both developed and developing nations is favoring the market growth. However, stringent regulations governing the disposal and reuse of syringes acts as a major restraining factor for market players. On the other hand, ongoing R&D to develop more user-friendly and affordable syringes provides new opportunities for market expansion. Syringe manufacturers are designing products with improved ergonomics, safety features, and offerings prefilled with drugs to increase adoption of syringes.

Key Features of the Study:

This report provides an in-depth analysis of the global syringe market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global syringe market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include ICU Medical, Inc., CODAN Companies, Catalent, Inc., BD, Hindustan Syringes & Medical Devices Ltd, Terumo Corporation, Schott AG, Cardinal Health, B. Braun SE, Gerresheimer AG, NIPRO, Gerresheimer AG, Dali Medical Devices, Zephyrus Innovations (Zephyrus), Stevanato Group, Xellia Pharmaceuticals, and Delta Med Group.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global syringe market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global syringe market.

Detailed Segmentation-

Usage:
- Sterilizable/Reusable Syringes
- Disposable Syringes
- Prefilled Syringes
Application:
- Insulin Syringes
- Botox
- Osteoarthritis
- Human Growth Hormone
- Others
End User:
- Hospitals
- Clinics
- Homecare Settings
- Others
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- ICU Medical, Inc.
- CODAN Companies
- Catalent, Inc.
- BD
- Hindustan Syringes & Medical Devices Ltd
- Terumo Corporation
- Schott AG
- Cardinal Health
- Braun SE
- Gerresheimer AG
- NIPRO
- Gerresheimer AG
- Dali Medical Devices
- Zephyrus Innovations (Zephyrus)
- Stevanato Group
- Xellia Pharmaceuticals
- Delta Med Group

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Usage
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Recent Developments
Pricing Analysis
Regulatory Scenario
Acquisitions and Partnerships Scenario
Product Launches/Approvals
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Syringe Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 impact on the market

5. Global Syringe Market, By Usage, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Sterilizable/Reusable Syringes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Disposable Syringes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Prefilled Syringes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Syringe Market, By Application, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Insulin Syringes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Botox
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Osteoarthritis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Human Growth Hormone
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Syringe Market, By End User, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Homecare Settings
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Syringe Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Regions, 2019-2031
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Usage, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Usage, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Usage, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Usage, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Usage, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Usage, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Company Profiles
- ICU Medical, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- CODAN Companies
- Catalent, Inc.
- BD
- Hindustan Syringes & Medical Devices Ltd
- Terumo Corporation
- Schott AG
- Cardinal Health
- B. Braun SE
- Gerresheimer AG
- NIPRO
- Gerresheimer AG
- Dali Medical Devices
- Zephyrus Innovations (Zephyrus)
- Stevanato Group
- Xellia Pharmaceuticals
- Delta Med Group